Search research articles
Contact Us
Filters
Showing results (441-450 of 1,860) with videos related to
Page
of 186
Sort By:
Journal of Cardiovascular Pharmacology
|
January 1, 1988
Calcium channel blockers in patients with both hypertension and angina pectoris
W H Frishman, E J Lazar
Expert Review of Cardiovascular Therapy
|
September 8, 2004
Amlodipine/atorvastatin: the first cross risk factor polypill for the prevention and treatment of cardiovascular disease
William H Frishman, Andrea L Zuckerman
Vision Research
|
February 1, 1995
Evidence for two sites of adaptation affecting the dark-adapted ERG of cats and primates
L J Frishman, P A Sieving
Pacing and Clinical Electrophysiology : PACE
|
May 1, 1982
Electropharmacology of the slow-channel inhibitors in the management of cardiac arrhythmias: verapamil
W H Frishman, T H LeJemtel
Journal of Structural Biology
|
March 6, 2019
Residue co-evolution helps predict interaction sites in α-helical membrane proteins
Bo Zeng, Peter Hönigschmid, Dmitrij Frishman
Cardiology in Review
|
September 13, 2012
Second-hand tobacco smoke and cardiovascular disease risk: an epidemiological review
Andrew Dunbar, William Gotsis, William Frishman
Cardiology in Review
|
February 12, 2025
Literature Review: Effects of Environmental Noise on the Cardiovascular Health
Andrew Jun Wang, William Howard Frishman
Journal of Neurophysiology
|
June 1, 1990
Origin of negative potentials in the light-adapted ERG of cat retina
L J Frishman, R H Steinberg
Nucleic Acids Research
|
June 21, 2013
Conservation of mRNA secondary structures may filter out mutations in Escherichia coli evolution
Andrey Chursov, Dmitrij Frishman, Alexander Shneider
Heart Disease (Hagerstown, Md.)
|
April 27, 2002
Systemic inflammation as a cardiovascular disease risk factor and as a potential target for drug therapy
R C Kaplan, W H Frishman
Page
of 186
Search research articles
Search
Showing results (441-450 of 1,860) with videos related to
Sort By:
Page
of 186
Journal of Cardiovascular Pharmacology
|
January 1, 1988
Calcium channel blockers in patients with both hypertension and angina pectoris
W H Frishman, E J Lazar
Expert Review of Cardiovascular Therapy
|
September 8, 2004
Amlodipine/atorvastatin: the first cross risk factor polypill for the prevention and treatment of cardiovascular disease
William H Frishman, Andrea L Zuckerman
Vision Research
|
February 1, 1995
Evidence for two sites of adaptation affecting the dark-adapted ERG of cats and primates
L J Frishman, P A Sieving
Pacing and Clinical Electrophysiology : PACE
|
May 1, 1982
Electropharmacology of the slow-channel inhibitors in the management of cardiac arrhythmias: verapamil
W H Frishman, T H LeJemtel
Journal of Structural Biology
|
March 6, 2019
Residue co-evolution helps predict interaction sites in α-helical membrane proteins
Bo Zeng, Peter Hönigschmid, Dmitrij Frishman
Cardiology in Review
|
September 13, 2012
Second-hand tobacco smoke and cardiovascular disease risk: an epidemiological review
Andrew Dunbar, William Gotsis, William Frishman
Cardiology in Review
|
February 12, 2025
Literature Review: Effects of Environmental Noise on the Cardiovascular Health
Andrew Jun Wang, William Howard Frishman
Journal of Neurophysiology
|
June 1, 1990
Origin of negative potentials in the light-adapted ERG of cat retina
L J Frishman, R H Steinberg
Nucleic Acids Research
|
June 21, 2013
Conservation of mRNA secondary structures may filter out mutations in Escherichia coli evolution
Andrey Chursov, Dmitrij Frishman, Alexander Shneider
Heart Disease (Hagerstown, Md.)
|
April 27, 2002
Systemic inflammation as a cardiovascular disease risk factor and as a potential target for drug therapy
R C Kaplan, W H Frishman
Page
of 186